DD251131A5 - Verfahren zur herstellung neuer trisubstituierter azacycloalkane bzw. azacycloalkene - Google Patents
Verfahren zur herstellung neuer trisubstituierter azacycloalkane bzw. azacycloalkene Download PDFInfo
- Publication number
- DD251131A5 DD251131A5 DD86285893A DD28589386A DD251131A5 DD 251131 A5 DD251131 A5 DD 251131A5 DD 86285893 A DD86285893 A DD 86285893A DD 28589386 A DD28589386 A DD 28589386A DD 251131 A5 DD251131 A5 DD 251131A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- ethyl
- indol
- salt
- hydroxy
- item
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- G—PHYSICS
- G05—CONTROLLING; REGULATING
- G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
- G05B2219/00—Program-control systems
- G05B2219/30—Nc systems
- G05B2219/35—Nc in input of data, input till input file format
- G05B2219/35287—Verify, check program by drawing, display part, testpiece
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1385 | 1985-01-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD251131A5 true DD251131A5 (de) | 1987-11-04 |
Family
ID=4177425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD86285893A DD251131A5 (de) | 1985-01-03 | 1986-01-02 | Verfahren zur herstellung neuer trisubstituierter azacycloalkane bzw. azacycloalkene |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0187619A3 (fr) |
| JP (2) | JPS61161279A (fr) |
| KR (1) | KR870006036A (fr) |
| AU (1) | AU5178786A (fr) |
| DD (1) | DD251131A5 (fr) |
| DK (1) | DK886A (fr) |
| FI (1) | FI855182L (fr) |
| GR (1) | GR860003B (fr) |
| HU (1) | HUT39442A (fr) |
| NO (1) | NO860008L (fr) |
| PT (1) | PT81781B (fr) |
| ZA (2) | ZA869B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3907974A1 (de) * | 1989-03-11 | 1990-09-13 | Merck Patent Gmbh | Indolderivate |
| US5428043A (en) * | 1990-02-08 | 1995-06-27 | Pfizer Inc. | Tricyclic-cyclic amines as novel cholinesterase inhibitors |
| TW197442B (fr) * | 1990-02-08 | 1993-01-01 | Pfizer | |
| KR100457857B1 (ko) * | 2002-05-23 | 2004-11-18 | (주) 비엔씨바이오팜 | 2-[2-(3-인돌릴)에틸아미노]피리딘 유도체, 그 제조방법및 이를 포함하는 항바이러스용 약학적 조성물 |
| BRPI0519585A2 (pt) * | 2004-12-20 | 2009-02-25 | Hoffmann La Roche | compostos de fàrmula i; processo para a fabricaÇço de compostos de fàrmula i; composiÇÕes farmacÊuticas; mÉtodo para o tratamento e/ou profilaxia de doenÇas que estço associadas com a dpp-iv e usos destes compostos |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3075986A (en) * | 1958-01-09 | 1963-01-29 | Rhone Poulenc Sa | (1-piperdidylalkyl) derivatives of 3-indole |
| US3183235A (en) * | 1961-06-27 | 1965-05-11 | Sterling Drug Inc | 1-[3-, 2-, and 1-indolyl-lower-alkanoyl] piperidines |
| US3238215A (en) * | 1963-10-17 | 1966-03-01 | Sterling Drug Inc | 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines |
| US3821387A (en) * | 1965-10-23 | 1974-06-28 | Robins Co Inc A H | The treatment of parkinsonism with 3-(omega-substituted alkyl)-indoles |
| GB1189064A (en) * | 1967-05-01 | 1970-04-22 | Sterling Drug Inc | Indole Derivatives |
| DE3233553A1 (de) * | 1982-09-10 | 1984-03-15 | Merck Patent Gmbh, 6100 Darmstadt | Pyrrolderivate |
| DE3342632A1 (de) * | 1983-11-25 | 1985-06-05 | Merck Patent Gmbh, 6100 Darmstadt | Indolderivate |
-
1985
- 1985-12-23 EP EP85810610A patent/EP0187619A3/fr not_active Withdrawn
- 1985-12-27 JP JP60293363A patent/JPS61161279A/ja active Pending
- 1985-12-27 JP JP60293362A patent/JPS61161258A/ja active Pending
- 1985-12-30 FI FI855182A patent/FI855182L/fi not_active Application Discontinuation
- 1985-12-31 KR KR1019850010042A patent/KR870006036A/ko not_active Withdrawn
-
1986
- 1986-01-02 NO NO860008A patent/NO860008L/no unknown
- 1986-01-02 AU AU51787/86A patent/AU5178786A/en not_active Abandoned
- 1986-01-02 DK DK886A patent/DK886A/da not_active Application Discontinuation
- 1986-01-02 PT PT81781A patent/PT81781B/pt unknown
- 1986-01-02 ZA ZA869A patent/ZA869B/xx unknown
- 1986-01-02 HU HU865A patent/HUT39442A/hu unknown
- 1986-01-02 DD DD86285893A patent/DD251131A5/de unknown
- 1986-01-02 GR GR860003A patent/GR860003B/el unknown
- 1986-01-02 ZA ZA8610A patent/ZA8610B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK886A (da) | 1986-07-04 |
| PT81781B (de) | 1987-11-05 |
| KR870006036A (ko) | 1987-07-08 |
| EP0187619A2 (fr) | 1986-07-16 |
| PT81781A (de) | 1986-02-01 |
| DK886D0 (da) | 1986-01-02 |
| HUT39442A (en) | 1986-09-29 |
| FI855182A7 (fi) | 1986-07-04 |
| EP0187619A3 (fr) | 1987-08-26 |
| AU5178786A (en) | 1986-07-17 |
| ZA8610B (en) | 1986-08-27 |
| JPS61161279A (ja) | 1986-07-21 |
| FI855182L (fi) | 1986-07-04 |
| ZA869B (en) | 1986-08-27 |
| NO860008L (no) | 1986-07-04 |
| JPS61161258A (ja) | 1986-07-21 |
| GR860003B (en) | 1986-04-25 |
| FI855182A0 (fi) | 1985-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69413542T2 (de) | Perhydroisoindolderivate als substanz p antagonisten | |
| DE69008012T2 (de) | 4-Fluorbenzolderivate, Herstellungsverfahren und diese enthaltende pharmazeutische Zusammensetzungen. | |
| EP0532456B1 (fr) | Dérivés de l'acyle-1-pipéridine et leur utilisation comme antagonistes du substance P | |
| EP0546388B1 (fr) | Azahétérocyclylméthyl-chromanes comme agents pour le traitement de maladies du système nerveux central | |
| DE2935772A1 (de) | Dihydropyridinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel | |
| DE69714265T2 (de) | Tetrahydrochinolinderivate als eaa antagonisten | |
| HU193229B (en) | Process for producing 1-benzyl-amino-methyl-pyrrolidinones and their acid addition salts | |
| DE69006907T2 (de) | Arylthiazolylimidazole als 5HT3-Antagonisten. | |
| DE69622731T2 (de) | Tetrahydrochinoline als nmda antagonisten | |
| DE69324212T2 (de) | Indol-7-carboxamide Derivate als Analgetika | |
| DE2822465C2 (de) | 2-substituierte trans-5-Phenyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indolderivate und diese enthaltende Arzneimittel | |
| DE69634183T2 (de) | Substituierte Heterocyclen | |
| DE68925173T2 (de) | 4-Methyl und 4-Ethyl substituierte Pyrrolidin-2-one | |
| EP0519291A1 (fr) | 2,3-Dihydropyrano (2,3-b) pyridines amino-méthyl-substituées, procédé pour leur préparation et leur utilisation en tant que médicaments | |
| DE60106572T2 (de) | IMIDAZOLVERBINDUNGEN ALS Alpha2-ADRENOREZEPTOREN ANTAGONISTEN | |
| EP0539803A1 (fr) | Triazaspirodecanone-méthyl-chromanes pour le traitement des maladies du système nerveux central | |
| EP0389425B1 (fr) | Benzothiopyranylamines | |
| DE69526595T2 (de) | Pyridoncarbonsäurederivate substituiert von bicyclischer aminogruppe, deren ester und salze, und bicyclisches amin als zwischenprodukt davon | |
| DE60010855T2 (de) | Phenylsulphonylderivative als 5-ht rezeptorliganden | |
| EP0187122A2 (fr) | Azacycloalkanes, azacycloalcènes 1,3,4-trisubstitués | |
| EP0128120A2 (fr) | Oxazolidinones substituées | |
| DD257430A5 (de) | Verfahren zur herstellung von pyrrolo(1,2-a)(4,1)benzoxarepinen | |
| DD216456A5 (de) | Verfahren zur herstellung neuer aralkyltriazolverbindungen | |
| DE68913167T2 (de) | Indol-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate. | |
| EP0187619A2 (fr) | Tétrahydropyridines 1,3-disubstituées |